Allogene Therapeutics
ALLO
#7442
Rank
NZ$0.55 B
Marketcap
$2.57
Share price
4.35%
Change (1 day)
-60.84%
Change (1 year)

Allogene Therapeutics (ALLO) - Cash on Hand

Cash on Hand as of December 2024 : NZ$0.52 Billion

According to Allogene Therapeutics 's latest financial reports the company has NZ$0.52 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Allogene Therapeutics - Cash on Hand chart (from 2018 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$0.51 B-26.91%
2023-12-31NZ$0.70 B-12.92%
2022-12-31NZ$0.81 B21.7%
2021-12-31NZ$0.66 B-41.65%
2020-12-31NZ$1.14 B45.66%
2019-12-31NZ$0.78 B15.02%
2018-12-31NZ$0.68 B
2017-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.45 B-12.49%๐Ÿ‡บ๐Ÿ‡ธ USA